GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inhibrx Biosciences Inc (NAS:INBX) » Definitions » Accumulated other comprehensive income (loss)

INBX (Inhibrx Biosciences) Accumulated other comprehensive income (loss) : $0.00 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Inhibrx Biosciences Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Inhibrx Biosciences's Accumulated other comprehensive income (loss) for the quarter that ended in Sep. 2024 was $0.00 Mil.

Inhibrx Biosciences Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Inhibrx Biosciences's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inhibrx Biosciences Accumulated other comprehensive income (loss) Chart

Inhibrx Biosciences Annual Data
Trend Dec22 Dec23
Accumulated other comprehensive income (loss)
- -

Inhibrx Biosciences Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial - - - - -

Inhibrx Biosciences Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Inhibrx Biosciences Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Inhibrx Biosciences's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Inhibrx Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inhibrx Biosciences Inc (NAS:INBX) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
PROK DRTS ZNTL ATAI NAUT PGEN LXEO IKT DMAC MGNX VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
11025 N. Torrey Pines Road, Suite 140, La Jolla, CA, USA, 92037
Website
https://www.inhibrx.com
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.